In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.

Moderna (NasdaqGS:MRNA) recently experienced significant index changes, with the company being added to the Russell Midcap and Midcap Value indexes, while being dropped from several others. Over the ...

Many of the 17 million projected to lose Medicaid coverage will turn to struggling free health clinics. They need more ...

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure ...

Major U.S. equities indexes were little changed at midday Wednesday after a report on wholesale inflation showed a surprising ...

The S&P 500 added 0.5% on Thursday, July 17, 2025, notching a record closing high for the first time in a week as June retail ...

A study of 1.2 million Danish children found no link between vaccines containing aluminum and an elevated risk for 50 ...

Carney claimed he had only cash and real estate holdings, and it turns out he held hundreds of stocks, stock options and ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Supporting cutting-edge research at colleges and universities — even, or especially, in its earliest stages, before anyone ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.